The authors reply
- PMID: 33883456
- DOI: 10.1097/CCM.0000000000005063
The authors reply
Comment on
-
Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in Coronavirus Disease 2019.Crit Care Med. 2021 Feb 1;49(2):e170-e178. doi: 10.1097/CCM.0000000000004786. Crit Care Med. 2021. PMID: 33201004
-
Potential Endotype Transition for Coronavirus Disease 2019-Related Sepsis With Longitudinal Transcriptome Profiling.Crit Care Med. 2021 Jul 1;49(7):e719-e720. doi: 10.1097/CCM.0000000000004975. Crit Care Med. 2021. PMID: 33769770 No abstract available.
References
-
- Ren X. Potential Endotype Transition for Coronavirus Disease 2019–Related Sepsis With Longitudinal Transcriptome Profiling. Crit Care Med. 2021; 49:e719–e720
-
- Sweeney TE, Liesenfeld O, Wacker J, et al. Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in coronavirus disease 2019. Crit Care Med. 2021; 49:e170–e178
-
- Sweeney TE, Azad TD, Donato M, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018; 46:915–925
-
- Russell CD, Baillie JK. Treatable traits and therapeutic targets: Goals for systems biology in infectious disease. Curr Opin Syst Biol. 2017; 2:140–146
-
- Sweeney TE, Khatri P. Generalizable biomarkers in critical care: Toward precision medicine. Crit Care Med. 2017; 45:934–939
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources